These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 10604642

  • 1. Hemolytic uremic syndrome: defining the need for long-term follow-up.
    Small G, Watson AR, Evans JH, Gallagher J.
    Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
    [Abstract] [Full Text] [Related]

  • 2. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
    Garg AX, Salvadori M, Okell JM, Thiessen-Philbrook HR, Suri RS, Filler G, Moist L, Matsell D, Clark WF.
    Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
    [Abstract] [Full Text] [Related]

  • 3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [Abstract] [Full Text] [Related]

  • 4. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
    Gagnadoux MF, Habib R, Gubler MC, Bacri JL, Broyer M.
    Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
    [Abstract] [Full Text] [Related]

  • 5. [Hemolytic uremic syndrome: long term renal injury].
    Lumbreras Fernández J, Cruz Rojo J, Iñigo Martín G, Muley Alonso R, Vara Martín J.
    An Pediatr (Barc); 2010 May; 72(5):309-16. PubMed ID: 20347408
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D, Moritz ML, Vats A, Janosky JE.
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [Abstract] [Full Text] [Related]

  • 7. [Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors].
    Zambrano O P, Delucchi B A, Cavagnaro S F, Hevia J P, Rosati M MP, Lagos R E, Nazal Ch V, González C C, Barrera B P, Alvarez L E, Pinto S V, Salas del C P, Cano Sch F, Contreras M A, Galanti de la P M, Gana A JC, Zamorano C J, Espinoza B A, Dreves R P, Pereira M J, Bidegain S A, Pasten P E, Yáñez P L, Cerda F V, Rodríguez S E, Aglony I M, Gutiérrez I E, Salas P F, Figueroa Y S, Valenzuela A M, Grandy H J, Guerra A B, Lapadula A M, Reutter de la M P, Gallardo T V, Maldonado S D, Azócar P M, Cavada Ch G.
    Rev Med Chil; 2008 Oct; 136(10):1240-6. PubMed ID: 19194619
    [Abstract] [Full Text] [Related]

  • 8. Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow.
    Hüseman D, Gellermann J, Vollmer I, Ohde I, Devaux S, Ehrich JH, Filler G.
    Pediatr Nephrol; 1999 Oct; 13(8):672-7. PubMed ID: 10502125
    [Abstract] [Full Text] [Related]

  • 9. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A.
    BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].
    Caletti MG, Gallo G.
    Medicina (B Aires); 2005 Jun 13; 65(6):528-32. PubMed ID: 16433483
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.
    Bláhová K, Janda J, Kreisinger J, Matejková E, Sedivá A.
    Pediatr Nephrol; 2002 Jun 13; 17(6):400-3. PubMed ID: 12107802
    [Abstract] [Full Text] [Related]

  • 14. Chronic renal failure in children.
    Hari P, Singla IK, Mantan M, Kanitkar M, Batra B, Bagga A.
    Indian Pediatr; 2003 Nov 13; 40(11):1035-42. PubMed ID: 14660834
    [Abstract] [Full Text] [Related]

  • 15. Short-term and long-term outcome of hemolytic uremic syndrome in Iranian children.
    Otukesh H, Hoseini R, Golnari P, Fereshtehnejad SM, Zamanfar D, Hooman N, Tabarroki A.
    J Nephrol; 2008 Nov 13; 21(5):694-703. PubMed ID: 18949724
    [Abstract] [Full Text] [Related]

  • 16. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B.
    Clin Transplant; 2005 Oct 13; 19(5):683-9. PubMed ID: 16146562
    [Abstract] [Full Text] [Related]

  • 17. [Hemolytic-uremic syndrome in children: a 19-year retrospective study].
    Imoberdorf G, Bianchetti MG, Rossi E, Gugler E, Oetliker OH.
    Schweiz Med Wochenschr; 1993 Jul 24; 123(29):1439-44. PubMed ID: 8367702
    [Abstract] [Full Text] [Related]

  • 18. Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome.
    Dieguez S, Ayuso S, Brindo M, Osinde E, Cánepa C.
    Nephron Clin Pract; 2004 Jul 24; 97(3):c118-22. PubMed ID: 15292689
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.
    Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J.
    Pediatr Nephrol; 2019 Apr 24; 34(4):657-662. PubMed ID: 30368614
    [Abstract] [Full Text] [Related]

  • 20. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K, Akkök N, Tinaztepe B.
    Turk J Pediatr; 1993 Apr 24; 35(1):23-36. PubMed ID: 8236514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.